Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Evoque TTVR system linked to favorable outcomes in new real-world analysis
Researchers tracked data from more than 1,000 real-world patients, focusing on 30-day safety and efficacy outcomes. The group shared its findings at TCT 2025 in San Francisco.
First-in-human data highlight IVL’s potential to treat more challenging lesions
Shockwave Medical and FastWave Medical have shared new first-in-human data on their advanced IVL offerings. Both companies are focused on addressing difficult-to-cross lesions that often cause problems for cardiologists.
Medicare now covers renal denervation for patients with uncontrolled hypertension
This decision expands access to renal denervation to many more patients throughout the United States. Recor Medical and Medtronic both gained FDA approval for their RDN systems in 2023, and other vendors are actively developing their own treatment options.
Clinical trials paused due to heart patient’s hospitalization
Intellia Therapeutics paused clinical trials for ATTR-CM and ATTR-PN after a patient was hospitalized due to a significant liver injury.
Massachusetts staffing agency, owner indicted for sending fake CNAs to nursing homes
The allegations are part of a 13-count indictment unveiled Monday by Massachusetts Attorney General Andrea Joy Campbell listing Blooming Staffing Agency, its owner and an employee as defendants. They are accused of billing nursing homes after knowingly placing unlicensed nursing assistants to care for elderly patients.

Researchers examined data from more than 98,000 patients who underwent transfemoral TAVR from January 2015 to March 2018.

The study, published in European Heart Journal, included decades of data from 20 different countries.

"Screening for CAS in adults without symptoms does more harm than good, and we continue to recommend against it," one USPSTF representative said.

Two specialists have shared their own perspective on the updated ACC/AHA guidelines in Circulation.

The system sends real-time feedback to healthcare providers during the treatment process.

Healthcare workers should pay close attention to any symptoms they experience after receiving a COVID-19 vaccine, according to a new analysis.

However, treatment with sacubitril/valsartan did not lead to improvements in hospitalizations for heart failure or all-cause mortality.

According to new data from the ongoing COMMENCE clinical trial, patients showed no signs of structural valve deterioration after five years.